NCOA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.196800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.586570E-01
Normal-vs-Stage2
5.742300E-03
Normal-vs-Stage3
5.215700E-03
Normal-vs-Stage4
6.423600E-02
Stage1-vs-Stage2
2.605400E-01
Stage1-vs-Stage3
8.947800E-02
Stage1-vs-Stage4
6.691600E-01
Stage2-vs-Stage3
1.470610E-01
Stage2-vs-Stage4
1.696970E-01
Stage3-vs-Stage4
4.920500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.719300E-03
Normal-vs-AfricanAmerican
2.801800E-01
Normal-vs-Asian
4.275100E-03
Caucasian-vs-AfricanAmerican
8.446400E-02
Caucasian-vs-Asian
1.663230E-01
AfricanAmerican-vs-Asian
3.737500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.295540E-02
Normal-vs-Female
4.542600E-03
Male-vs-Female
7.492200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.642200E-02
Normal-vs-Age(41-60Yrs)
2.733800E-02
Normal-vs-Age(61-80Yrs)
5.480800E-03
Normal-vs-Age(81-100Yrs)
4.837200E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.250000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.159600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.649980E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.875800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.234500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.817370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.838200E-03
Normal-vs-Daily Drinker
3.542100E-03
Normal-vs-Weekly Drinker
9.122400E-03
Normal-vs-Occasional Drinker
1.181860E-02
Normal-vs-Social Drinker
1.014630E-01
Non Drinker-vs-Daily Drinker
7.220000E-01
Non Drinker-vs-Weekly Drinker
9.729200E-01
Non Drinker-vs-Occasional Drinker
2.477400E-01
Non Drinker-vs-Social Drinker
1.723610E-01
Daily Drinker-vs-Weekly Drinker
7.965000E-01
Daily Drinker-vs-Occasional Drinker
4.163600E-01
Daily Drinker-vs-Social Drinker
2.937400E-01
Weekly Drinker-vs-Occasional Drinker
3.530800E-01
Weekly Drinker-vs-Social Drinker
2.911600E-01
Occasional Drinker-vs-Social Drinker
6.965400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.964110E-02
Normal-vs-Grade 2
9.440000E-03
Normal-vs-Grade 3
8.604600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.368000E-01
Grade 1-vs-Grade 3
5.085800E-01
Grade 1-vs-Grade 4
1.964110E-02
Grade 2-vs-Grade 3
6.412200E-01
Grade 2-vs-Grade 4
9.440000E-03
Grade 3-vs-Grade 4
8.604600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.022900E-03
Normal-vs-NonDiabetic
3.663600E-03
Diabetic-vs-NonDiabetic
8.982800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.739300E-03
Normal-vs-NoPancreatitis
4.281300E-03
Pancreatitis-vs-NoPancreatitis
6.281800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.294250E-02
Normal-vs-N1
7.763400E-03
N0-vs-N1
7.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.699300E-03
Normal-vs-TP53-NonMutant
1.301830E-01
TP53-Mutant-vs-TP53-NonMutant
1.620300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
